In a filing, Vertex Pharmaceuticals, Inc. revealed its SVP & Chief Accounting Officer Ambrose Kristen unloaded Company’s shares for reported $0.1 million on Apr 02 ’24. In the deal valued at $419.00 per share,240 shares were sold. As a result of this transaction, Ambrose Kristen now holds 7,500 shares worth roughly $2.97 million.
Then, Arbuckle Stuart A sold 5,034 shares, generating $2,142,974 in total proceeds. Upon selling the shares at $425.70, the EVP, COO now owns 49,691 shares.
Before that, ALTSHULER DAVID sold 4,239 shares. Vertex Pharmaceuticals, Inc. shares valued at $1,804,542 were divested by the EVP, Global Research and CSO at a price of $425.70 per share. As a result of the transaction, ALTSHULER DAVID now holds 25,813 shares, worth roughly $10.24 million.
Evercore ISI upgraded its Vertex Pharmaceuticals, Inc. [VRTX] rating to an Outperform from a an In-line in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Evercore ISI also remained covering VRTX and has decreased its forecast on February 06, 2024 with a “an In-line” recommendation from previously “an Outperform” rating. Bernstein revised its rating on February 02, 2024. It rated VRTX as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc. [NASDAQ:VRTX] saw its stock fall -0.92% to $396.55. Over the last five days, the stock has lost -2.49%. Vertex Pharmaceuticals, Inc. shares have fallen nearly -2.54% since the year began. Nevertheless, the stocks have risen 21.50% over the past one year. While a 52-week high of $448.40 was reached on 01/30/24, a 52-week low of $316.43 was recorded on 04/12/24. SMA at 50 days reached $416.72, while 200 days put it at $380.98. A total of 1.2 million shares were traded, compared to the trading of 1.06 million shares in the previous session.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 393.49, which if violated will result in even more drops to 390.44. On the upside, there is a resistance level at 399.87. A further resistance level may holdings at 403.20. The Relative Strength Index (RSI) on the 14-day chart is 34.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -10.61, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.92%. Stochastics %K at 13.61% indicates the stock is a buying.
